• Clinical Evidence

Proof in the (Sugar-Free) Pudding: Implementing Computerized Insulin Drip Management

Setting: 114-bed not-for-profit community hospital affiliated with a major academic medical center

Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results

  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.

Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.

Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results
  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.
Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.

References

Authors

Karen Mahnke, MSN, RN, NEA-BC; Anthony Pick, MD; Laura Meller, MS, APRN, NE-BC; Samy Gonstal, BSN, CCRN; Chris Somberg, MS, APRN-CNS, ACNS-BC, NE-BC.

Source

Presented at Vizient Connections Summit.

Year

2022

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results
  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.
Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.

References

Authors

Karen Mahnke, MSN, RN, NEA-BC; Anthony Pick, MD; Laura Meller, MS, APRN, NE-BC; Samy Gonstal, BSN, CCRN; Chris Somberg, MS, APRN-CNS, ACNS-BC, NE-BC.

Source

Presented at Vizient Connections Summit.

Year

2022

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.